Investors Sue Fertility Treatment Co. Following FDA Letter
By Emily Atkin ( September 16, 2013, 6:00 PM EDT) -- OvaScience Inc. and its top brass were hit with a putative shareholder class action Monday following a company announcement that it was suspending trials of its flagship fertility treatment because of drug classification concerns by the U.S. Food and Drug Administration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.